141 results on '"Mok, T S"'
Search Results
2. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3. Supplement to: Osimertinib or platinum—pemetrexed in EGFR T790M—positive lung cancer.
4. Overview of current systemic management of EGFR-mutant NSCLC
5. Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
6. Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
7. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor
8. A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
9. Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer
10. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
11. Supplement to: Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
12. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
13. Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients
14. A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
15. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity
16. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma
17. Failure analysis of miniaturized multilayer ceramic capacitors in surface mount printed circuit board assemblies
18. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
19. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial
20. Corrigendum: Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2018) 29 (iv192–iv237) DOI: 10.1093/annonc/mdy275)
21. Metastatic non-small cell lung cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
22. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy
23. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
24. Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death
25. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor
26. Lung Cancer Working Group Report
27. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study
28. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer
29. Better survival with epidermal growth factor receptor exon 19 deletion than with exon 21 mutation in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals
30. A randomized phase II study of gemcitabine (G) vs gemcitabine/carboplatin (GC) as consolidation therapy to concurrent chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC): A Lung Cancer Research Group (LCRG) study
31. Efficacy and safety of erlotinib in >1200 East/South-East (E/SE) Asian patients (pts) with advanced non-small-cell lung cancer (NSCLC)
32. Molecular and clinical subgroup analyses from a phase III trial comparing gefitinib with docetaxel in previously treated non-small cell lung cancer (INTEREST)
33. T790M mutation and c-MET amplification might be correlated to TTP of EGFR-TKI in NSCLC
34. Serial alpha-feto protein in predicting radiological response and overall survival of patient with inoperable hepatocellular carcinoma (HCC) during chemotherapy
35. Prognostic system for hepatitis B virus (HBV)-related hepatocellular carcinoma- Prospective validation of the Chinese University Prognostic Index
36. FAST-ACT: A phase II randomized double-blind trial of sequential erlotinib and chemotherapy as first-line treatment in patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC)
37. Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis
38. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
39. Evaluation of patupilone as monotherapy in patients with advanced hepatocellular carcinoma (HCC)
40. Transarterial ethanol ablation of unresectable hepatocellular carcinoma with lipiodol-ethanol mixture (LEM): A phase II study
41. Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma
42. A phase III study of doxorubicin (A) versus cisplatin (P)/ interferonα-2b (I)/ doxorubicin (A)/ fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC)
43. A new randomized phase II design for testing investigational drugs in hepatocellular carcinoma (HCC)
44. Analysis of a tunable frequency-selective surface on an in-plane biased ferrite substrate
45. Analysis of frequency-selective surfaces on a biased ferrite substrate
46. 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor.
47. The cost of palliative care for hepatocellular carcinoma in Hong Kong.
48. Sonographic findings in masseter-muscle metastases.
49. Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.
50. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.